278
Participants
Start Date
June 14, 2017
Primary Completion Date
November 30, 2017
Study Completion Date
July 25, 2022
Gene Expression Profiling
SkylineDx has previously developed the MMprofiler, a microarray-based diagnostic test that can subtype MM patients and reliably predict MM patient survival (prognosis). In this project, the test's clinical value will be expanded to include the prediction of treatment effectiveness in individual patients based on Gene Expression Profiling.
University of Turin, Turin
Mario Boccadoro
OTHER